Martin Münchbach
Dr. Münchbach is an investment advisor for BB BIOTECH VENTURES. He has invested in life science companies across all stages and types. Before becoming a venture capitalist, Dr. Münchbach gained experience in strategic marketing at Sanofi-Synthélabo. Dr. Münchbach holds a PhD in Protein Chemistry, an MSc in Biochemistry and a Master in Industrial Engineering and Management from the Swiss Federal Institute of Technology (ETH), Zurich. Dr. Münchbach’s current board assignments include BioVascular Inc, Molecular Partners AG, Optimer Pharmaceuticals Inc, Radius Health Inc, and Tioga Pharmaceuticals Inc.